Related Experiment Video
Updated: Nov 15, 2025

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
Drimane Derivatives as the First Examples of Covalent BH3 Mimetics that Target MCL-1
Florian Daressy1,2,3, Florian Malard1, Line Seguy4
1Institut de Chimie des Substances Naturelles, CNRS UPR 2301, Université Paris-Saclay, Avenue de la terrasse, 91198, Gif-sur-Yvette Cedex, France.
Drimane sesquiterpenoids are natural compounds that inhibit MCL-1 and BCL-xL proteins, crucial in cancer. These compounds covalently bind MCL-1, inducing cancer cell death and apoptosis.
Area of Science:
- Natural product chemistry
- Cancer biology
- Molecular pharmacology
Background:
- Drimane sesquiterpenoid dialdehydes exhibit antiproliferative effects.
- The precise mechanism of action for these compounds remains largely unknown.
- MCL-1 and BCL-xL, anti-apoptotic proteins of the BCL-2 family, are frequently overexpressed in various cancers, particularly lymphoid malignancies.
Purpose of the Study:
- To elucidate the molecular mechanism underlying the antiproliferative activity of drimane sesquiterpenoid dialdehydes.
- To identify specific BCL-2 family proteins targeted by these natural compounds.
- To investigate the structure-activity relationships of drimanes concerning their inhibitory potential.
Main Methods:
- Inhibition assays to assess the activity of drimanes against MCL-1 and BCL-xL.
- NMR spectroscopy and mass spectrometry to analyze compound binding and adduct formation.
- Chemical synthesis to create and test structural variants of drimanes.
- Cytotoxic assays using cancer cell lines, including a MCL-1/BCL-xL-dependent line (BL2).
Main Results:
- Several drimanes were identified as potent inhibitors of MCL-1 and BCL-xL.
- Structural modifications significantly impacted the inhibitory activity and selectivity.
- The two most potent compounds demonstrated selectivity for MCL-1, binding to its BH3 groove.
- Evidence of covalent inhibition of MCL-1 via pyrrole adduct formation was established through spectroscopic and synthetic analyses.
- These selective compounds induced apoptosis and exhibited cytotoxicity specifically in the BL2 cell line.
Conclusions:
- Drimane sesquiterpenoid dialdehydes are effective covalent inhibitors of MCL-1.
- Their mechanism involves binding to the BH3 groove and forming a pyrrole adduct with MCL-1.
- These compounds display selective cytotoxicity against cancer cells dependent on MCL-1/BCL-xL.
- This study reveals a novel mode of action for drimanes with potential therapeutic implications in cancer treatment.
Related Concept Videos
Electrophilic 1,2- and 1,4-Addition of X2 to 1,3-Butadiene
Electrophilic 1,2- and 1,4-Addition of HX to 1,3-Butadiene
Alcohols from Carbonyl Compounds: Reduction
Catalytic hydrogenation is similar to the reduction of an alkene or alkyne by adding H2 across the pi bond in the presence of transition metal catalysts like Raney Ni, Pd–C, Pt, or Ru. Aldehydes and ketones can be reduced by this method, often under mild to moderate heat (25–100°C) and...
Preparation of Diols and Pinacol Rearrangement
The reaction begins with transferring a proton from the acid catalyst to one of the hydroxyl groups, producing an oxonium ion.
Formation of Halohydrin from Alkenes

